obesity drug news today glp-1 september 29 2025 Use of diabetes and anti-obesity drugs surges nationwide New oral GLP-1 drug delivers
Description
All three tirzepatide doses achieved greater A1C and weight reductions compared to semaglutide
Demand for GLP-1s, including Novo Nordisk's weight loss treatment Wegovy and diabetes injection Ozempic, has outstripped supply over the last year in the U.S
AbdulkhalikovaDSustarsicAVrtanik BokalEJancarNJensterleMBurnik PaplerT
GLP-1 agonists (GLP-1s) and GLP-1/GIP agonists are a group of medicines that boost the actions of hormones we already make in our body called incretin hormones
J Nat Prod
doi: 10.1111/bcp.13688
